Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Four countries to boycott Eurovision 2026 over Israel’s inclusion - 2Fireballs and a full moon. Here’s how to see two celestial events this week
- 3Hubble Space Telescope spies dusty debris from two cosmic collisions
- 4NASA's Voyager 1 set to achieve historic distance from Earth
- 5As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- Yemen's Houthis ready to join Iran war if needed, raising new shipping risk
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Explosions heard across Tehran after IDF announces wave of strikes on regime terror targets
- 'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed
- Step by step instructions to Protect Your Senior Condo for Ideal Wellbeing and Solace
- How did Ariana Grande get her Glinda voice? I’m the man behind the magic.
- Exploring the School Application Cycle: Understudy Bits of knowledge
- James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
